Skip to content

LISATA THERAPEUTICS, INC.: 10-Q filed 2014-10-30

What LISATA THERAPEUTICS, INC. reported in its quarterly report filed 2014-10-30 (fiscal Q3 2014): 43 published measures, 118 facts as tagged in accession 0000320017-14-000070.

This filing

Form
10-Q (quarterly report)
Filed
2014-10-30
Fiscal period
fiscal Q3 2014
Accession
0000320017-14-000070 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All LISATA THERAPEUTICS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2014-09-30131,338,677USD
At 2013-12-3189,816,082USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2014-09-3069,279,705USD
At 2013-12-3127,789,647USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2014-09-3063,003,272USD
At 2013-12-3162,542,475USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2014-09-3032,141,286USD
At 2013-12-3146,133,759USD
At 2013-09-3016,946,200USD
At 2012-12-3113,737,452USD

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2014-01-01 to 2014-09-30-35,991,241USD273
2013-01-01 to 2013-09-30-19,737,699USD273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2014-01-01 to 2014-09-302,925,918USD273
2013-01-01 to 2013-09-30948,644USD273

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2014-07-01 to 2014-09-304,117,783USD92
2014-01-01 to 2014-09-3012,662,290USD273
2013-07-01 to 2013-09-303,706,918USD92
2013-01-01 to 2013-09-3010,590,237USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2014-01-01 to 2014-09-3025,546,121USD273
2013-01-01 to 2013-09-3023,895,091USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2014-01-01 to 2014-09-30-3,547,353USD273
2013-01-01 to 2013-09-30-948,644USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2014-09-30-279,634,948USD
At 2013-12-31-236,373,605USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2014-07-01 to 2014-09-3047,387USD92
2014-01-01 to 2014-09-30142,183USD273
2013-07-01 to 2013-09-3044,757USD92
2013-01-01 to 2013-09-30492,325USD273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2014-09-3015,686,609USD
At 2013-12-3112,844,216USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2014-07-01 to 2014-09-30-16,258,500USD92
2014-01-01 to 2014-09-30-42,187,930USD273
2013-07-01 to 2013-09-30-9,312,831USD92
2013-01-01 to 2013-09-30-26,314,385USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2014-09-3041,413,941USD
At 2013-12-3150,826,750USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2014-07-01 to 2014-09-30183,477USD92
2014-01-01 to 2014-09-30383,539USD273
2013-07-01 to 2013-09-3098,618USD92
2013-01-01 to 2013-09-30208,023USD273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2014-09-3011,854,615USD
At 2013-12-319,806,919USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2014-09-304,400,437USD
At 2013-12-313,354,908USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2014-09-3025,209,336USD
At 2014-05-0814,091,700USD
At 2013-12-3111,117,770USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2014-09-3047,711,700USD
At 2013-12-3113,875,600USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2014-09-302,088,888USD
At 2013-12-311,860,835USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2014-07-01 to 2014-09-3020,376,283USD92
2014-01-01 to 2014-09-3054,850,220USD273
2013-07-01 to 2013-09-3013,019,749USD92
2013-01-01 to 2013-09-3036,904,622USD273

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2014-09-302,142,302USD
At 2013-12-311,270,223USD

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2014-07-01 to 2014-09-304,012,369USD92
2014-01-01 to 2014-09-3011,515,168USD273
2013-07-01 to 2013-09-302,975,935USD92
2013-01-01 to 2013-09-309,603,048USD273

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2014-07-01 to 2014-09-307,894,291USD92
2014-01-01 to 2014-09-3024,310,324USD273
2013-07-01 to 2013-09-305,557,425USD92
2013-01-01 to 2013-09-3015,681,731USD273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2014-07-01 to 2014-09-308,469,623USD92
2014-01-01 to 2014-09-3019,024,728USD273
2013-07-01 to 2013-09-304,486,389USD92
2013-01-01 to 2013-09-3011,619,843USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2014-09-3035,485,523shares
At 2013-12-3127,196,537shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2014-09-30343,308,264USD
At 2013-12-31299,594,525USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2014-09-3062,058,972USD
At 2013-12-3162,026,435USD
At 2013-09-3035,134,395USD
At 2012-12-3132,820,159USD

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

PeriodValueUnitDays
At 2014-09-3019,500,000USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2014-09-3047,711,709USD
At 2013-12-3113,875,617USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2014-09-301,317,082USD
At 2013-12-311,151,729USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2014-09-30616,000USD
At 2013-12-31598,729USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2014-09-302,818,623USD
At 2013-12-314,018,026USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2014-09-304,376,353USD
At 2013-12-311,561,933USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2014-07-01 to 2014-09-30-17,129,257USD92
2014-01-01 to 2014-09-30-43,634,037USD273
2013-07-01 to 2013-09-30-9,231,844USD92
2013-01-01 to 2013-09-30-26,274,247USD273

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2014-07-01 to 2014-09-30-17,176,644USD92
2014-01-01 to 2014-09-30-43,776,220USD273
2013-07-01 to 2013-09-30-9,276,601USD92
2013-01-01 to 2013-09-30-26,766,572USD273

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2014-07-01 to 2014-09-30-16,975,155USD92
2014-01-01 to 2014-09-30-43,261,231USD273
2013-07-01 to 2013-09-30-9,070,757USD92
2013-01-01 to 2013-09-30-26,446,692USD273

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2014-07-01 to 2014-09-30-16,974,269USD92
2014-01-01 to 2014-09-30-43,261,343USD273
2013-07-01 to 2013-09-30-9,070,757USD92
2013-01-01 to 2013-09-30-26,446,692USD273

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2014-01-01 to 2014-09-30453,900USD273
2013-01-01 to 2013-09-30453,900USD273

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2014-07-01 to 2014-09-30-687,280USD92
2014-01-01 to 2014-09-30-1,062,568USD273
2013-07-01 to 2013-09-30179,605USD92
2013-01-01 to 2013-09-30248,161USD273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2014-07-01 to 2014-09-30-870,757USD92
2014-01-01 to 2014-09-30-1,446,107USD273
2013-07-01 to 2013-09-3080,987USD92
2013-01-01 to 2013-09-3040,138USD273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2014-01-01 to 2014-09-30177,162USD273
2013-01-01 to 2013-09-30108,363USD273

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2014-01-01 to 2014-09-30872,079USD273
2013-01-01 to 2013-09-30-583,659USD273

Inspect the source

Entity
LISATA THERAPEUTICS, INC. / CIK 0000320017
Captured
2026-09-19T14:56:51.274Z
SEC response SHA-256
cea21c045f03a86f28b8ca2c2ed8647182755ec7b9afe40200702f5307c095db

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000320017.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))